Evidence map›Paper›PMID 30319257›Full record

ReviewInternational journal of nanomedicine2018

Advanced nanomaterials targeting hypoxia to enhance radiotherapy.

Jia Li, Wenting Shang, Yong Li, Sirui Fu, Jie Tian, Ligong Lu

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy.International journal of nanomedicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jia LiZhuhai Precision Medical Center, Zhuhai People's Hospital, Jinan University, Zhuhai, China, luligong1969@126.com.
Wenting ShangCAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China, jie.tian@ia.ac.cn.
Yong LiZhuhai Precision Medical Center, Zhuhai People's Hospital, Jinan University, Zhuhai, China, luligong1969@126.com.
Sirui FuZhuhai Precision Medical Center, Zhuhai People's Hospital, Jinan University, Zhuhai, China, luligong1969@126.com.
Jie TianCAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China, jie.tian@ia.ac.cn.
Ligong LuZhuhai Precision Medical Center, Zhuhai People's Hospital, Jinan University, Zhuhai, China, luligong1969@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia within solid tumors is often responsible for the failure of radiotherapy. The development of hypoxia-targeting nanomaterials - aimed at enhancing the effect of radiotherapy by electrical or heat effects and at modulating hypoxia in the tumor microenvironment - is a promising strategy to address this issue. We provide an overview of recently developed advanced materials that potentiate radiotherapy. First, we summarize novel materials for oxygen delivery or production to modify the tumor microenvironment, thus improving the effects of ionizing radiation. Second, we present new approaches for the design of high-

Indexed as

AnimalsCell HypoxiaDrug Delivery SystemsHumansNanoparticlesNanostructuresNeoplasmsRadiation Tolerancehypoxiahypoxia-inducible factor 1nanomaterialsradiotherapy

Identifiers

PMID30319257
PMCPMC6171520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.